SlimSEB Probiotic-Enzyme Blend Beat Placebo—But There's a Catch
A probiotic, enzyme and botanical blend called SlimSEB beat placebo in a 12-week randomized trial of 87 adults at risk of type 2 diabetes. Obese participants lost 4.5 kg more than placebo and trimmed their waists by 11 cm, while cholesterol and insulin resistance also improved. But the product was supplied by its maker, the trial was small and short, and the multi-ingredient formula means no single component can take credit. Here is what the data show, how they compare with GLP-1 drugs, and who should think twice.
Forskolin Fat Burner: 2 kg in 12 Weeks—Modest but Real?
Forskolin has been hyped as a fat-burning miracle for years, but does a new 2026 trial finally give it some real backing? In 60 overweight adults over 12 weeks, a Coleus forskohlii extract beat placebo by about 1.93 kg in body weight and 1.83 cm in waist size, with better triglycerides and HDL. Safety markers looked clean too. But the study was quasi-randomized, small, and run by the product's manufacturer, and the effect is a rounding error next to GLP-1 drugs. Here's what the data really say and how to approach forskolin with realistic expectations.